Research at Oslo University Hospital

In order to stimulate excellent research and draw attention to the hospital's research activity, Oslo University Hospital rewards outstanding publications every half-year. 

Six research groups were awarded for their excellent papers published the second half-year of 2020 during a ceremony on June 11th.  Each group received NOK 50.000 for use in further research, and the prize winners gave  short presentations of their main findings. These are available via YouTube.

The Research Council of Norway is announcing up to NOK 160 million in R&D support for Innovation Projects for the Public Sector. A funding of NOK 49 million is available for innovation in and for the public sector that contributes to good solutions to specific challenges in the health and welfare services. 

Funding scale: NOK 3 000 000-7 000 000

Application deadline: 15 September 2021

The Life Science Cluster has appointed OUS scientists Jan Terje Andersen and Per Morten Sandset as new board members.

The Life Science Cluster is a network for all companies and organizations for which the life sciences are key. This includes health and medicine where Norway’s advanced healthcare system forms a unique basis for the development of new technology.

The South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF) announces approximately NOK 130 million for health research funding in the region.

The call is open to all research areas. A portion of the funds will be targeted at projects within four thematic areas.

Application deadline is Thursday, September 2nd 2021 16:00.

In the largest genetic study of bipolar disorder to date, researchers within the Psychiatric Genomics Consortium have identified 64 regions of the genome containing DNA variations that increase risk of bipolar disorder - more than double the number of regions previously identified. The results were published in the prestigious scientific journal Nature Genetics on May 17.

Several researchers from NORMENT contributed to the work, which was headed by Centre leader Ole A. Andreassen.

On this web page you will find an overview over planned and ongoing clinical trials and other research projects at Oslo University Hospital related to COVID-19 and SARS CoV-2 infection. The information has been retrieved from applications to the regional ethics committee, the Norwegian Research Council, other funding sources, or directly from the researchers behind the projects.
An updated list of publications related to COVID-19 research at Oslo University Hospital can be found here.

Cell and gene therapy form two of the most dynamic research areas world-wide and provide fundamentally new therapies for diseases without available treatment. A donor consortium consisting of Svanhild and Arne Must´s Foundation for Medical Research (lead donor), RADFORSK oncology research fund and the Norwegian Cancer Society, has committed 50 MNOK to form a Centre for Advanced Cell and Gene therapy (ACT Centre) located in clean room facilities at the OUH. The launching of the centre was covered by the Norwegian Broadcasting Corporation (NRK) May 2nd.

The Annual Report from the Institute for Cancer Research for 2020 is now published.
Institute head Kjetil Taskén says: "We have kept the activity up through the pandemic based on the production numbers. You can read about the exciting research by almost 400 people in 25 research groups and 6 core facilities at the ICR. Activities in the CanCell CoE, two KG Jebsen Centres and two OUH strategic research areas and other activities in precision medicine and cell therapy where our researchers are involved are also covered."

The Research Council of Norway, Oslo University Hospital, and the Faculty of Medicine, UiO invite researchers to a webinar about funding of health and medical research in Horizon Europe.
Time and place: May 11, 2021 1:00 PM–4:00 PM, on Zoom
Deadline for registration: May 7
The event is co-hosted by Research Council Norway, Oslo University Hospital and Faculty of Medicine at UIO, and is primarily targeted towards researchers at OUS and UiO interested in Horizon Europe and funding opportunities therein.